Evommune, Inc. (EVMN)
How it compares with the broader market is one of its lowest-scoring factors; company finances score is on the low side; and price trend is one of its lowest-scoring factors.
EVMN scores higher than 3% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, Evommune, Inc. (EVMN) scores 17 out of 100 on the Market Census six-factor composite, which puts it at the Low score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.62× 30-day average
- 52-week range
- —
- Market cap
- $350.22M
- Earnings date
- 9 Dec 2026
- Volume
- 557,955
- Avg. volume (30d)
- 894,643
- Open
- 6.40
- Previous close
- 6.41
- Day's range (regular session)
- 6.17 – 6.44
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.47
- P/E (TTM)
- —
- EPS (TTM)
- -3.83
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about EVMN right now
Evommune, Inc. (EVMN) currently scores 17/100 on the Market Census six-factor composite, at the Low score level. EVMN is -2.50% on the day and -9.68% over five sessions as of the most recent tick. Low is the lowest level. Much of EVMN's data reads poorly right now. Market Census does not tell you to short it; the level only describes the data. EVMN's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about EVMN itself. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See EVMN in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent EVMN news
Latest headlines that name Evommune, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Evommune Presents Late-Breaking Phase 2a Proof-of-Concept Data Evaluating EVO301 in Atopic Dermatitis at European Academy of Dermatology and Venereology CongressYahoo
- Evommune Presents Additional Data From Phase 2a Proof-Of-Concept Trial Of EVO301 In Adults With Atopic Dermatitis At EADV 2026 Congress; Plan To Initiate Subcutaneous Phase 2b Dose-Ranging Trial In Mid-2027Benzinga
- Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 CongressYahoo
- Evommune To Present Results From Phase 2a Study Of EVO301 In Moderate-To-Severe Atopic Dermatitis At European Academy Of Dermatology & Venereology CongressBenzinga
- Evommune: Pipeline Reset After EVO756 Failure, All Eyes On EVO301SeekingAlpha
We hide 9 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to EVMN’s 17, all within 1 point.
Sorted by closeness to EVMN’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.